Which medication should be avoided in the treatment of anorexia and bulimia?

Wellbutrin, or bupropion, should be avoided in the treatment of anorexia and bulimia primarily due to the increased risk of seizures, particularly in individuals who are malnourished or have electrolyte imbalances, which are common in these eating disorders. Bupropion is contraindicated in patients with a history of eating disorders because the risk of seizures correlates with low body weight and the potential for electrolyte abnormalities.

When treating conditions like anorexia and bulimia, it is crucial to ensure that medications do not exacerbate health problems or introduce additional risks. Methylphenidate and atomoxetine, while used cautiously, can sometimes help manage associated symptoms such as attention difficulties. Buspirone, generally considered safer in these contexts, is primarily used for anxiety but does not have the same risk profile as bupropion regarding seizure potential.

Overall, the avoidance of Wellbutrin is rooted in the need for safe management of eating disorders, where maintaining stability is vital to patient care.